Probi AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PROB.ST research report →
Companywww.probi.com
Probi AB (publ) researches, develops, manufactures, markets, and sells probiotics for health, pharmaceutical, and food companies. The company conducts research primarily in the fields of gastrointestinal health, digestive health, immune health, bone health, and iron absorption, as well as children's, women's, and senior health. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, and recovery drinks.
- CEO
- Anita Johansen
- IPO
- 2004
- Employees
- 157
- HQ
- Lund, SE
Price Chart
Valuation
- Market Cap
- $3.97B
- P/E
- 235.75
- P/S
- 6.32
- P/B
- 2.90
- EV/EBITDA
- 31.91
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 35.08%
- Op Margin
- 1.80%
- Net Margin
- 2.68%
- ROE
- 1.21%
- ROIC
- 0.77%
Growth & Income
- Revenue
- $627.69M · 1.52%
- Net Income
- $16.82M · -58.60%
- EPS
- $1.48 · -58.54%
- Op Income
- $11.32M
- FCF YoY
- -65.72%
Performance & Tape
- 52W High
- $352.00
- 52W Low
- $197.50
- 50D MA
- $348.26
- 200D MA
- $284.42
- Beta
- 0.46
- Avg Volume
- 9.49K
Get TickerSpark's AI analysis on PROB.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PROB.ST Coverage
We haven't published any research on PROB.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PROB.ST Report →